BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 17940512)

  • 21. Generation of MCF-7 cells with aggressive metastatic potential in vitro and in vivo.
    Ziegler E; Hansen MT; Haase M; Emons G; Gründker C
    Breast Cancer Res Treat; 2014 Nov; 148(2):269-77. PubMed ID: 25292421
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Decreased TUSC3 Promotes Pancreatic Cancer Proliferation, Invasion and Metastasis.
    Fan X; Zhang X; Shen J; Zhao H; Yu X; Chen Y; Zhuang Z; Deng X; Feng H; Wang Y; Peng L
    PLoS One; 2016; 11(2):e0149028. PubMed ID: 26871953
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Re-expression of reduced VEGF activity in liver metastases of experimental pancreatic cancer.
    Fukuhara M; Uchida E; Tajiri T; Aimoto T; Naito Z; Ishiwata T
    J Nippon Med Sch; 2005 Jun; 72(3):155-64. PubMed ID: 16046832
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Function and clinical relevance of RHAMM isoforms in pancreatic tumor progression.
    Choi S; Wang D; Chen X; Tang LH; Verma A; Chen Z; Kim BJ; Selesner L; Robzyk K; Zhang G; Pang S; Han T; Chan CS; Fahey TJ; Elemento O; Du YN
    Mol Cancer; 2019 May; 18(1):92. PubMed ID: 31072393
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
    Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
    World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gene expression accurately distinguishes liver metastases of small bowel and pancreas neuroendocrine tumors.
    Sherman SK; Maxwell JE; Carr JC; Wang D; Bellizzi AM; Sue O'Dorisio M; O'Dorisio TM; Howe JR
    Clin Exp Metastasis; 2014 Dec; 31(8):935-44. PubMed ID: 25241033
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gene expression profiles of pancreatic cancer and stromal desmoplasia.
    Crnogorac-Jurcevic T; Efthimiou E; Capelli P; Blaveri E; Baron A; Terris B; Jones M; Tyson K; Bassi C; Scarpa A; Lemoine NR
    Oncogene; 2001 Nov; 20(50):7437-46. PubMed ID: 11704875
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stomatin‑like protein 2 induces metastasis by regulating the expression of a rate‑limiting enzyme of the hexosamine biosynthetic pathway in pancreatic cancer.
    Chao D; Ariake K; Sato S; Ohtsuka H; Takadate T; Ishida M; Masuda K; Maeda S; Miura T; Mitachi K; Yu XJ; Fujishima F; Mizuma M; Nakagawa K; Morikawa T; Kamei T; Unno M
    Oncol Rep; 2021 Jun; 45(6):. PubMed ID: 33846782
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA-301a promotes pancreatic cancer invasion and metastasis through the JAK/STAT3 signaling pathway by targeting SOCS5.
    Hu H; Zhang Q; Chen W; Wu T; Liu S; Li X; Luo B; Zhang T; Yan G; Lu H; Lu Z
    Carcinogenesis; 2020 Jun; 41(4):502-514. PubMed ID: 31233116
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lentivirus-mediated shRNA interference targeting vascular endothelial growth factor inhibits angiogenesis and progression of human pancreatic carcinoma.
    Zhao X; Zhu DM; Gan WJ; Li Z; Zhang JL; Zhao H; Zhou J; Li DC
    Oncol Rep; 2013 Mar; 29(3):1019-26. PubMed ID: 23254994
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Invasion front-specific overexpression of tissue inhibitor of metalloproteinase-1 in liver metastases from colorectal cancer.
    Kahlert C; Bandapalli OR; Schirmacher P; Weitz J; Brand K
    Anticancer Res; 2008; 28(3A):1459-65. PubMed ID: 18630499
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Qingyihuaji formula inhibits progress of liver metastases from advanced pancreatic cancer xenograft by targeting to decrease expression of Cyr61 and VEGF.
    Yin JH; Shi WD; Zhu XY; Chen Z; Liu LM
    Integr Cancer Ther; 2012 Mar; 11(1):37-47. PubMed ID: 21382954
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oligonucleotide microarray identifies genes differentially expressed during tumorigenesis of DMBA-induced pancreatic cancer in rats.
    Guo JC; Li J; Yang YC; Zhou L; Zhang TP; Zhao YP
    PLoS One; 2013; 8(12):e82910. PubMed ID: 24376604
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibitory effect of a matrix metalloproteinase inhibitor on growth and spread of human pancreatic ductal adenocarcinoma evaluated in an orthotopic severe combined immunodeficient (SCID) mouse model.
    Alves F; Borchers U; Padge B; Augustin H; Nebendahl K; Klöppel G; Tietze LF
    Cancer Lett; 2001 Apr; 165(2):161-70. PubMed ID: 11275365
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Loss of HIF1A From Pancreatic Cancer Cells Increases Expression of PPP1R1B and Degradation of p53 to Promote Invasion and Metastasis.
    Tiwari A; Tashiro K; Dixit A; Soni A; Vogel K; Hall B; Shafqat I; Slaughter J; Param N; Le A; Saunders E; Paithane U; Garcia G; Campos AR; Zettervall J; Carlson M; Starr TK; Marahrens Y; Deshpande AJ; Commisso C; Provenzano PP; Bagchi A
    Gastroenterology; 2020 Nov; 159(5):1882-1897.e5. PubMed ID: 32768595
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Integration of Genomic and Transcriptional Features in Pancreatic Cancer Reveals Increased Cell Cycle Progression in Metastases.
    Connor AA; Denroche RE; Jang GH; Lemire M; Zhang A; Chan-Seng-Yue M; Wilson G; Grant RC; Merico D; Lungu I; Bartlett JMS; Chadwick D; Liang SB; Eagles J; Mbabaali F; Miller JK; Krzyzanowski P; Armstrong H; Luo X; Jorgensen LGT; Romero JM; Bavi P; Fischer SE; Serra S; Hafezi-Bakhtiari S; Caglar D; Roehrl MHA; Cleary S; Hollingsworth MA; Petersen GM; Thayer S; Law CHL; Nanji S; Golan T; Smith AL; Borgida A; Dodd A; Hedley D; Wouters BG; O'Kane GM; Wilson JM; Zogopoulos G; Notta F; Knox JJ; Gallinger S
    Cancer Cell; 2019 Feb; 35(2):267-282.e7. PubMed ID: 30686769
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pancreatic cancer stem-like cells display aggressive behavior mediated via activation of FoxQ1.
    Bao B; Azmi AS; Aboukameel A; Ahmad A; Bolling-Fischer A; Sethi S; Ali S; Li Y; Kong D; Banerjee S; Back J; Sarkar FH
    J Biol Chem; 2014 May; 289(21):14520-33. PubMed ID: 24719318
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Invasive markers identified by gene expression profiling in pancreatic cancer.
    Rogers A; Smith MJ; Doolan P; Clarke C; Clynes M; Murphy JF; McDermott A; Swan N; Crotty P; Ridgway PF; Conlon KC
    Pancreatology; 2012; 12(2):130-40. PubMed ID: 22487523
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Consensus transcriptome signature of perineural invasion in pancreatic carcinoma.
    Abiatari I; DeOliveira T; Kerkadze V; Schwager C; Esposito I; Giese NA; Huber P; Bergman F; Abdollahi A; Friess H; Kleeff J
    Mol Cancer Ther; 2009 Jun; 8(6):1494-504. PubMed ID: 19509238
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Secreted interleukin-1alpha induces a metastatic phenotype in pancreatic cancer by sustaining a constitutive activation of nuclear factor-kappaB.
    Melisi D; Niu J; Chang Z; Xia Q; Peng B; Ishiyama S; Evans DB; Chiao PJ
    Mol Cancer Res; 2009 May; 7(5):624-33. PubMed ID: 19435817
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.